Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Indian Bank Launches SME Drug Maker Pollution Loans

This article was originally published in PharmAsia News

Executive Summary

The State Bank of India says it will make available loans to small and medium-size pharmaceutical companies to help their facilities meet environmental standards. The targeted firms for the specially designed loans primarily are bulk drug makers. Meeting environmental standards is important to the companies that expect to qualify for U.S. FDA certification for exporting to the United States. The bank launched the loan program on a pilot basis in Andhra Pradesh. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068380

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel